Rare Thyroid Therapeutics
An innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€7m (Public information from Oct 2020)
Stockholms kommun Stockholm County (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | <1m | <1m | <1m | 1.5m | 2.0m |
| % growth | - | - | - | 58 % | 28 % | 214 % | 29 % |
| EBITDA | - | - | (<1m) | (1.4m) | (3.0m) | (4.2m) | (11.9m) |
| % EBITDA margin | - | - | (62 %) | (355 %) | (619 %) | (277 %) | (606 %) |
| Profit | (<1m) | (<1m) | (<1m) | (1.5m) | (3.1m) | (4.3m) | (12.0m) |
| % profit margin | - | - | (116 %) | (383 %) | (641 %) | (284 %) | (607 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
€460k | Grant | ||
SEK60.0m Valuation: SEK60.0m 17.3x EV/LTM Revenues -4.9x EV/LTM EBITDA | Acquisition | ||
| Total Funding | €460k | ||
Recent News about Rare Thyroid Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.